Results 191 to 200 of about 35,609 (280)

AI‐assisted basal cell carcinoma diagnosis with LC‐OCT: A multicentric retrospective study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Real‐time AI assistance significantly improves dermatologists' performance in diagnosing basal cell carcinoma with LC‐OCT, outperforming traditional imaging methods. AI‐assisted novices reached expert‐level performance, bridging a 2‐year expertise gap, thus supporting a broader clinical adoption of non‐invasive technologies, reducing the need for ...
Sébastien Fischman, Théo Viel, Jean‐Luc Perrot, Javiera Pérez‐Anker, Mariano Suppa, Elisa Cinotti, Clément Lenoir, Carmen Orte Cano, Julia Welzel, Sandra Schuh, Elke Christina Sattler, Véronique del Marmol, Pietro Rubegni, Martina Dragotto, Vittoria Cioppa, Francesca Falcinelli, Simone Cappilli, Steven Challe, Clara Tavernier, Josep Malvehy, Linda Tognetti, LC‐OCT Reviewers Consortium, Sarah Hobelsberger, Maximilian Deussing, Sandra Schuh, Simone Cappilli, Hanna Wirsching, Gerardo Palmisano, Hervé Garat, Jean‐Luc Perrot, Simone Soglia, Vinzent Kevin Ortner, Kevin Jacobsen, Sarah Kourdjee, Marco Mozaffari, Javiera Anker, Julia Welzel, Julian Steininger, Claire Thibaud, Kristina Fünfer, Francesco Lacarrubba, Frank Friedrich Gellrich, Lucas Boussingault, Christian Dorado Cortez, Carmen Orte Cano, Clément Lenoir, Tom Wolswijk, Marina Thomas, Marina Venturini, Margot Fontaine, Marie Danset, Anna Elisa Verzì, Cristel Ruini, Martina Dragotto, Alessandro Di Stefani, Agnes Venturi, Jilliana Monnier, Romain Samaran, Gwendoline Diet, Vittoria Cioppa, Elke Sattler, Lyna Mtimet, Francesca Falcinelli, Elisa Cinotti, Mariano Suppa   +64 more
wiley   +1 more source

Dysregulation of innate and adaptive lymphoid immunity may have implications for symptom attribution and predict responses to targeted therapies in neuropsychiatric systemic lupus erythematosus. [PDF]

J Transl Autoimmun
Lindblom J, Barturen G, Beretta L, Toro-Domínguez D, Carnero-Montoro E, Borghi MO, Castillo J, Iacobaeus E, Enman Y, PRECISESADS Clinical Consortium, Mohan C, Alarcón-Riquelme ME, Nikolopoulos D, Parodis I.   +13 more
europepmc   +1 more source

Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologics

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Forty‐three HS specialists from 22 European countries reported adherence to HS guidelines and use of antibiotics before biologics despite limited efficacy and rapid relapse (49% within 1–3 months). Seventy‐nine per cent supported short‐term biologics for severe Hurley I disease.
Georgios Nikolakis, Erkan Alpsoy, Monika Arenbergerova, Falk G. Bechara, Farida Benhadou, Joana Cabete, Raffaele Dante Caposiena Caro, Giovanni Damiani, Maia Delage Toriel, Veronique Del Marmol, Valentina Dini, Evangelos J. Giamarellos‐Bourboulis, Katalin Glasenhardt, Philippe Guillem, Ariela Hafner, Evgeniya Hristakieva, John R. Ingram, Vaiva Jarienè, Gregor B. E. Jemec, Niamh Kearney, Brian Kirby, Natalia Kirsten, Piotr K. Krajewski, Vesta Kucinskiene, Aikaterini I. Liakou, Flavia Manzo Margiotta, Angelo V. Marzano, Antonio Martorell, Lukasz Matusiak, Dillon Mintoff, Alejandro Molina Leyva, Francesca Prignano, Tadas Raudonis, Hans Christian Ring, Marco Romanelli, Samed Şahin, Ditte M. L. Saunte, Linnea Thorlacius, Thrasyvoulos Tzellos, Hessel H. Van Der Zee, Kelsey Van Straalen, Christos C. Zouboulis   +41 more
wiley   +1 more source

Modulation of Glutathione-S-Transferase by Phytochemicals: To Activate or Inhibit-That Is the Question. [PDF]

Int J Mol Sci
Stoian IA, Vlad A, Gilca M, Dragos D.
europepmc   +1 more source

Messages for ultraviolet‐radiation protection to fair‐skinned populations

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This expert consensus summarizes messages for UV protection in fair‐skinned populations. Key messages include no sunbathing or tanning, no sunbeds. UV protection measures are to be used from UV index 3. Priority is given to shade and physical protection. Sunscreen with a strong SPF is to be used on uncovered areas.
Lieve Brochez, Claus Garbe, Teresa Amaral, Petr Arenberger, Violeta Astratinei, Philippe Autier, Marianne Berwick, Matilda Bylaite, Brigitte Boonen, Veronique del Marmol, Brigitte Dreno, Maria Concetta Fargnoli, Adele C. Green, Rüdiger Greinert, Axel Hauschild, Catherine A. Harwood, Isabelle Hoorens, Lidija Kandolf, Roland Kaufmann, Nicole Kelleners‐Smeets, Aimilios Lallas, Celeste Lebbé, Ulrike Leiter, Henry W. Lim, Caterina Longo, Joseph Malvehy, David Moreno, Fredrik Östman, Giovanni Pellacani, Ketty Peris, Caroline Robert, Bettina Ryll, Philippe Saiag, Dirk Schadendorf, Peter Soyer, Gilliosa Spurrier‐Bernard, Eggert Stockfleth, Alex Stratigos, Hisashi Uhara, Ricardo Vieira, Martin A. Weinstock, Dagmar Whitaker, David C. Whiteman, Iris Zalaudek, Ana‐Maria Forsea, EADO Task Force for Prevention and Early Detection of Skin Cancer   +45 more
wiley   +1 more source

MITF, TFEB, and TFE3 drive distinct adaptive gene expression programs and immune infiltration in melanoma. [PDF]

Cell Rep
Dias D, Oliveira E, Martí-Díaz R, Andrews S, Chocarro-Calvo A, Bellini A, Mosteo L, García YV, Chauhan J, Li L, García-Martinez JM, Rodriguez-López JN, Maria-Engler SS, Kenny C, Martínez-Useros J, García-Jiménez C, Sanchez-Del-Campo L, Louphrasitthiphol P, Goding CR.   +18 more
europepmc   +1 more source

Compraventas especiales excluidas del foro especial por razón de la materia del artículo 7.1 b del Reglamento Bruselas I bis ((Special Sales Excluded from the Special Forum by Reason of the Subject Matter of Article 7.1 B) of the Brussels I Bis Regulation)

, 2019
Isabel Lorente Martínez
openalex   +1 more source

Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This Delphi Consensus study identified upgrade criteria for the use of biologics and small molecules as first‐line therapy in hidradenitis suppurativa (HS). European HS experts evaluated 16 clinical scenarios, voting on eligibility for therapy escalation.
Georgios Nikolakis, Erkan Alpsoy, Florian Anzengruber, Matthias Augustin, Falk G. Bechara, Pierre‐André Becherel, Farida Benhadou, Vincenzo Bettoli, Joana Cabete, Raffaele Dante Caposiena Caro, Antonella Di Cesare, Giovanni Damiani, Valentina Dini, Evangelos J. Giamarellos‐Bourboulis, Krisztián Gáspár, Katalin Glasenhardt, Philippe Guillem, Ariela Hafner, Barbara Horvath, John R. Ingram, Vaiva Jarienè, Gregor B. E. Jemec, Alexander Katoulis, Natalia Kirsten, Georgios Kokolakis, Piotr K. Krajewski, Aikaterini I. Liakou, Flavia Manzo Margiotta, Angelo V. Marzano, Antonio Martorell, Lukasz Matusiak, Dillon Mintoff, Alejandro Molina Leyva, Andreas Pinter, Anna Pirogova, Maurizio Podda, Francesca Prignano, Jorge Romani, Marco Romanelli, Elia Rosi, Samed Sahin, Ditte M. L. Saunte, Sylke Schneider‐Burrus, Mariano Suppa, Jacek Szepietowski, Andrea Szegedi, Simon Francis Thomsen, Thrasyvoulos Tzellos, Anastasia Trigoni, Hessel H. Van Der Zee, Kelsey Van Straalen, Skaidra Valiukevičiene, Eva Vilarrasa, Esther von Stebut, Christos C. Zouboulis   +54 more
wiley   +1 more source

DNA Hypomethylation Underlies Epigenetic Swapping between AGO1 and AGO1-V2 Isoforms in Tumors. [PDF]

Epigenomes
Fain JS, Wangermez C, Loriot A, Denoue C, De Smet C.   +4 more
europepmc   +1 more source

Market Shares as a Collusive Marker: Evidence From the European Truck Industry

Journal of Economics &Management Strategy, EarlyView.
ABSTRACT Collusion theory robustly predicts non‐cartel rivals will raise their prices and increase their output. As a typical cartel cuts back production, its competitors are expected to gain market share during the collusive period and to lose market share in the period following the cartel's demise. We provide empirical support for this prediction by
Andreas Bovin, Iwan Bos
wiley   +1 more source